Associations between polymorphisms in DNA repair genes and TP53 mutations in non-small cell lung cancer

Lung Cancer

Volumn 73, Issue 1, 2011, Pages 25-31

  Cho, Sukki ^a   Kim, Min Jung ^b   Choi, Yi Young ^b   Yoo, Seung Soo ^a   Lee, Won Kee ^b   Lee, Eun Jin ^a   Jang, Eun Jeong ^a   Bae, Eun Young ^a   Jin, Guang ^b,c   Jeon, Hyo Sung ^a,b   Lee, Shin Yup ^a   Cha, Sung Ick ^a   Park, Tae In ^b   Kim, Chang Ho ^a   Park, Jae Yong ^a,b  

^a Kyungpook National University Hospital   (South Korea)

^b Kyungpook National University School of Medicine   (South Korea)

^c YANBIAN UNIVERSITY   (China)

Author keywords

DNA repair gene; Mutation; Polymorphism; TP53

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; EXON; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; GENOTYPE; HEREDITY; HUMAN; HUMAN TISSUE; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK; RNA SPLICING; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; DNA REPAIR; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79957683687     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2010.10.023     Document Type: Article

References (50)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Sekido Y., Fong K.M., Minna J.D. Molecular genetics of lung cancer. Ann Rev Med 2003, 54:73-87.
3. Schwartz A.G., Prysak G.M., Bock C.H., Cote M.L. The molecular epidemiology of lung cancer. Carcinogenesis 2007, 28:507-518.
4. Davies H., Hunter C., Smith R., Stephens P., Greenman C., Bignell G., et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res 2005, 65:7591-7595.
5. Ding L., Getz G., Wheeler D.A., Mardis E.R., McLellan M.D., Cibulskis K., et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 2008, 455:1069-1075.
6. Greenbalt M.S., Bennett W.P., Hollstein M., Harris C.C. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54:4855-4878.
7. Bennett W.P., Colby T.V., Travis W.D., Borkowski A., Jones R.T., Lane D.P., et al. p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res 1993, 53:4817-4822.
8. Slebos R.J., Baas I.O., Clement M.J., Offerhaus G.J., Askin F.B., Hruban R.H., et al. p53 alterations in atypical adenomatous hyperplasia of the human lung. Hum Pathol 1998, 29:801-808.
9. Gao W., Mady H.H., Melhem M.F., Keohavong P. Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients. Mol Carciong 2009, 48:633-641.
10. Yokota J., Kohno T. Molecular footprints of human lung cancer progression. Cancer Sci 2004, 95:197-204.
11. Hoeijmakers J.H.J. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
12. Ronen A., Glickman B.W. Human DNA repair genes. Environ Mol Mutagen 2001, 37:241-283.
13. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in human: an epidemiologic review. J Natl Cancer Inst 2000, 92:874-897.
14. Hou S.M., Falt S., Angelini S., Yang K., Nyberg F., Lambert B., et al. The XPD variant alleles are associated with increased aromatic DNA adduct level and lung cancer risk. Carcinogenesis 2002, 23:599-603.
15. Spitz M.R., Wei Q., Dong Q., Amos C.I., Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomarkers Prev 2003, 12:689-698.
16. Gao W.M., Romkes M., Day R.D., Siegfried J.M., Luketich J.D., Mady H.H., et al. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer. Carcinogenesis 2003, 24:1671-1676.
17. Hou S.M., Ryk C., Kannio A., Angelini S., Falt S., Nyberg F., et al. Influence of common XPD and XRCC1 alleles on p53 mutations in lung tumors. Environ Mol Mutagen 2003, 41:37-42.
18. Gao W.M., Romkes M., Siegfried J.M., Luketich J.D., Keohavong P. Polymorphisms in DNA repair genes XPD and XRCC1 and p53 mutations in lung carcinomas of never-smokers. Mol Carcinog 2006, 45:828-832.
19. Lee E.B., Jin G., Lee S.Y., Park J.Y., Kim M.J., Choi J.E., et al. TP53 mutations in Korean patients with non-small cell lung cancer. J Korean Med Sci 2010, 25:698-705.
20. Mountain C.F. Revisions in the International System for Staging Lung Cancer. Chest 1997, 111:1710-1717.
21. Spitz M.R., Wu X., Wang Y., Wang L.E., Shete S., Amos C.I., et al. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res 2001, 61:1354-1357.
22. Park J.Y., Park S.H., Choi J.E., Lee S.Y., Jeon H.S., Cha S.I., et al. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2002, 11:993-997.
23. Jeon H.S., Kim K.M., Park S.H., Lee S.Y., Choi J.E., Lee G.Y., et al. Relationship between XPG codon 1104 polymorphism and risk of primary lung cancer. Carcinogenesis 2003, 24:1677-1681.
24. Hao B., Wang H., Zhou K., Li Y., Chen X., Zhou G., et al. Identification of genetic variants in base excision repair pathways and their associations with risk of esophageal squamous cell carcinoma. Cancer Res 2004, 64:4378-4384.
25. Park S.H., Lee G.Y., Jeon H.S., Lee S.J., Kim K.M., Jang J.S., et al. 93G→A polymorphism of hMLH1 and risk of primary lung cancer. Int J Cancer 2004, 112:678-682.
26. Lee G.Y., Jang J.S., Lee S.Y., Jeon H.S., Kim K.M., Choi J.E., et al. XPC polymorphisms and lung cancer risk. Int J Cancer 2005, 115:807-813.
27. Chae M.H., Jang J.S., Kang H.G., Park J.H., Park J.M., Lee W.K., et al. O-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer. Mol Carcinog 2006, 45:239-249.
28. Medina P.P., Ahrendt S.A., Pollan M., Fernandez P., Sidransky D., Sanchez-Cespedes M. Screening of homologous recombination gene polymorphisms in lung cancer patients reveals an association of the NBS1-185Gln variant and p53 gene mutations. Cancer Epidemiol Biomarkers Prev 2003, 12:699-704.
29. Jung C.Y., Choi J.E., Park J.M., Chae M.H., Kang H.G., Kim K.M., et al. Polymorphisms in the hMSH2 gene and risk of primary lung cancer. Cancer Epidemiol Biomarkers Prev 2006, 15:762-768.
30. Kim J.H., Kim H., Lee K.Y., Choe K.H., Ryu J.S., Yoon H.I., et al. Genetic polymorphisms of ataxia telangiectasia mutated affect lung cancer risk. Hum Mol Genet 2006, 15:1181-1186.
31. Matullo G., Dunning A.M., Guarrera S., Baynes C., Polidoro S., Garte S., et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis 2006, 27(5):997-1007.
32. Kiyohara C., Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int J Med Sci 2007, 4:59-71.
33. Wu X., Zhao H., Wei Q., Amos C.I., Zhang K., Guo Z., et al. XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis 2003, 24:505-509.
34. Wang F., He Y., Guo H., Li J., Yang Y., Wu Z., et al. Genetic variants of nucleotide excision repair genes are associated with DNA damage in coke oven works. Cancer Epidemiol Biomarkers Prev 2010, 19:211-218.
35. Butkiewicz D., Popanda O., Risch A., Edler L., Dienemann H., Schulz V., et al. Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol Biomarkers Prev 2004, 13:2242-2246.
36. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004, 25:757-763.
37. Park J.Y., Lee S.Y., Jeon H.S., Park S.H., Bae N.C., Lee E.B., et al. Lys751Gln polymorphism in the DNA repair gene XPD and risk of primary lung cancer. Lung Cancer 2002, 36:15-16.
38. Kohno T., Shinmura K., Tosaka M., Tani M., Kim S.R., Nohmi T., et al. Genetic polymorphisms and alternative splicing of the hOGG1 gene, that is involved in the repair of 8-hydroxyguanine in damaged DNA. Oncogene 1998, 16:3219-3225.
39. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a huge review. Am J Epidemiol 2005, 162:925-942.
40. Masutani M., Nakagama H., Sugimura T. Poly(ADP-ribosyl)ation in relation to cancer and autoimmune disease. Cell Mol Life Sci 2005, 62:769-783.
41. Zhang X., Miao X., Liang G., Hao B., Wang Y., Tan W., et al. Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 2005, 65:722-726.
42. Li C., Hu Z., Lu J., Liu Z., Wang L.E., El-Naggar A.K., et al. Genetic polymorphisms in DNA base-excision repair genes ADPRT, XRCC1, and APE1 and the risk of squamous cell carcinoma of the head and neck. Cancer 2007, 110:867-875.
43. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. Am J Hum Genet 2007, 80:531-538.
44. Arthur L.M., Gustausson K., Hopfner K.P., Carson C.T., Stracker T.H., Karcher A., et al. Structural and functional analysis of Me11-3. Nucleic Acids Res 2004, 32:1886-1893.
45. Ryk C., Kumar R., Thirumaran R.K., Hou S.M. Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 2006, 54:285-292.
46. Matullo G., Peluso M., Polidoro S., Guarrera S., Munnia A., Krogh V., et al. Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003, 12:674-677.
47. Sun S., Schiller J.H., Gazdar A.F. Lung cancer in never-smokers - a different disease. Nat Rev Cancer 2007, 7:778-790.
48. Rudin C.M., Avila-Tang E., Harris C.C., Herman J.G., Hirsch F.R., Pao W., et al. Lung cancer in never smokers: molecular profiles and therapeutic implications. Clin Cancer Res 2009, 15:5646-5661.
49. Chanock S.J., Manolio T., Boehnke M., Boerwinkle E., Hunter D.J., Thomas G., et al. Replicating genotype-phenotype associations. Nature 2007, 447:655-660.
50. Taylor J.M.G., Ankerst D.P., Andridge R.R. Validation of biomark-based prediction models. Clin Cancer Res 2008, 14:5977-5983.